A Study Of VR To Improve Tolerability During Paracentesis And Liver Biopsies

Overview

About this study

The purpose of this study is to assess the effectiveness of VR during paracentesis and liver biopsy in increasing tolerability compared to relaxation music (control) using validated patient-reported outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients ≥18 years of age scheduled for outpatient paracentesis or ultrasound-guided liver biopsy.

  • Willingness to participate in study.

  • Ability to independently complete all study-related surveys.

Exclusion Criteria:

  • Significant visual or auditory impairment.

  • New opioid use within 12 hours of procedure.

  • History of severe vertigo, vomiting, or motion sickness.

  • Cognitive impairment limiting informed consent or survey completion.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/18/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Xiao Jing Wang

Open for enrollment

Contact information:

Ryeesa Amin

(507) 284-5278

amin.ryeesa@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597366

Mayo Clinic Footer